ARA MAY DELA TORRE: Open Payments
NPI 1881188761 · HENDERSON, NV. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$892 in 39 payments from 9 companies in 2025. Trend: 2023 $996 · 2024 $611 · 2025 $892
Food & beverage: $847Education: $45
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 11 | $294 |
| Amgen Inc. | 10 | $174 |
| Janssen Biotech, Inc. | 7 | $168 |
| GlaxoSmithKline, LLC. | 3 | $60 |
| E.R. Squibb & Sons, L.L.C. | 3 | $58 |
| UCB, Inc. | 2 | $58 |
| Octapharma USA, Inc. | 1 | $34 |
| Organon LLC | 1 | $28 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $18 |
Products named: RINVOQ, Otezla, TREMFYA, BENLYSTA, ORENCIA, Bimzelx, OCTAGAM IMMUNE GLOBULIN (HUMAN), HADLIMA.
Industry payments across NV — which companies pay providers there.
